Dexcom (DXCM) Change in Cash (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Cash data on file, last reported at $199.3 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 33.3% year-over-year to $199.3 million in Q1 2026; TTM through Mar 2026 was $212.3 million, a 295.34% increase from a year earlier, with the FY2025 full-year figure at $311.8 million, up 683.42% from the prior year.
• Change in Cash for Q1 2026 stood at $199.3 million, up from -$917.8 million in the prior quarter.
• Over the last five years, Change in Cash for DXCM reached as high as $676.6 million in Q3 2025 and fell as low as -$917.8 million in Q4 2025.
• Historically, Change in Cash has averaged $3.8 million across 5 years, with a median of -$15.1 million in 2024.
• Across the five-year window, Change in Cash surged 2862.18% in 2023 and slumped 5978.15% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$55.8 million in 2022, then tumbled by 38.53% to -$77.3 million in 2023, then jumped by 80.47% to -$15.1 million in 2024, then slumped by 5978.15% to -$917.8 million in 2025, then surged by 121.71% to $199.3 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $199.3 million in Q1 2026, -$917.8 million in Q4 2025, and $676.6 million in Q3 2025.